Skip to Main Content

Paper Details

Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727).
Clin Cancer Res
1
2023
693 gene expression modules, BRCA1/2, DDR, Metastatic Triple-Negative Breast Cancer, Primary, TNT, Tumor-infiltrating lymphocytes, carboplatin, docetaxel, germline, immune, immune-depleted, immune-depleted cluster, immune-related signatures, mTNBC, metastatic triple-negative breast cancer, participants, patients, total RNA, transcriptional, tumors
Author NameAffiliation
Joel S ParkerLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Joel S ParkerLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Katherine A HoadleyLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Katherine A HoadleyLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Charles M PerouLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Syed HaiderBreast Cancer Now Toby Robinsons Research Centre, The Institute of Cancer Research
  • 1 - 6

Datasets

Release 1.2